Lecture

Preclinical and Clinical Trials in SMA Gene Therapy

Description

This lecture covers preclinical and clinical trials in spinal muscular atrophy (SMA) gene therapy, discussing the demonstration of potency in mice, efficiency in patients, phase 1 trial results, further trials by Novartis, adverse effects, cellular targeting, and future perspectives in genome engineering and therapeutic strategies.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.